• TP53 and DNA Damage Pathways Shape Calicheamicin ADC Respons

  2026-07-28

  This study employs genome-wide CRISPR screening to identify TP53 and DNA damage response genes as key modulators of calicheamicin-based antibody–drug conjugate (ADC) efficacy in acute leukemia. The findings clarify critical resistance mechanisms and highlight actionable targets for combination therapies, offering a foundation for refining ADC-based leukemia treatments.

• Practical Use of 740 Y-P: PI 3-Kinase Activator in Cell Assa

  2026-07-27

  740 Y-P is a potent, cell-permeable PI 3-kinase activator designed to modulate the PI3K/AKT pathway in biochemical and cellular research. It is best suited for in vitro applications in cancer research, vesicular trafficking studies, and neuronal cell survival assays where precise activation of PI3K is required. Direct in vivo or animal use is not recommended due to solubility and molecular weight constraints.

• NETs Activate cGAS-STING Pathway in Surgical Brain Injury

  2026-07-27

  This study uncovers how neutrophil extracellular traps (NETs) exacerbate surgical brain injury (SBI) by activating the cGAS-STING signaling pathway, driving neuroinflammation and neuronal damage. By dissecting the mechanistic link between NETs and STING-mediated innate immune responses, the research suggests new therapeutic angles for SBI, including NET inhibition and modulation of cGAS-STING activity.

• Dabigatran in Stroke Prevention and Thromboembolic Disorders

  2026-07-26

  The reviewed study provides a comprehensive evaluation of Dabigatran as the first direct thrombin inhibitor among non-vitamin K oral anticoagulants (NOACs), highlighting its efficacy, safety, and practical benefits over traditional agents like warfarin. Key findings include superior stroke prevention in atrial fibrillation, comparable or improved safety profiles, and simplified dosing regimens, with critical insights for both clinical and translational research.

• GDC-0068 (RG7440): Advanced Pan-AKT Inhibition Protocols

  2026-07-25

  GDC-0068 (RG7440) empowers researchers to dissect PI3K/Akt/mTOR signaling with exceptional selectivity and reproducibility, even in challenging cancer models. This guide details optimized workflows, spatial pathway control strategies, and troubleshooting tips to unlock the full potential of this pan-AKT inhibitor.

• Applied Workflows with Protease Inhibitor Cocktail EDTA-Free

  2026-07-24

  Unlock reproducible, phosphorylation-sensitive protein analysis using the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). Discover protocol enhancements, troubleshooting tactics, and translational insights directly informed by breakthrough mitochondrial-targeting research.

• Cyanine 5-dCTP: Precision Fluorescent DNA Labeling in EOS

  2026-07-24

  Cyanine 5-dCTP empowers researchers to achieve high-efficiency, red-fluorescent labeling of DNA, especially in advanced enzymatic oligonucleotide synthesis workflows. By leveraging innovations in DNA nanostructure interfaces and robust protocol parameters, this reagent unlocks new performance standards in nucleic acid detection, probe synthesis, and fluorescence microscopy.

• Amphotericin B: Polyene Antifungal Benchmarks & Mechanistic

  2026-07-23

  Amphotericin B, a polyene antifungal antibiotic, exhibits potent and well-characterized activity against life-threatening fungal pathogens. Its mechanism involves ergosterol binding and membrane disruption, making it a mainstay in fungal infection research. This article details verifiable parameters, mechanistic insights, and protocol-critical considerations for bench scientists.

• iRGD-Modified RBC Membranes Enhance PDT in Neuroblastoma

  2026-07-23

  This study introduces iRGD-functionalized red blood cell membrane nanocarriers to significantly improve the efficacy of photodynamic therapy (PDT) against neuroblastoma. By combining biomimetic membrane technology with targeted delivery, the research demonstrates marked improvements in drug encapsulation, tumor penetration, and therapeutic outcomes.

• ABT-888 (Veliparib): Optimizing DNA Repair Inhibition Assays

  2026-07-22

  ABT-888 (Veliparib) empowers researchers to precisely inhibit PARP1/2, unlocking new strategies for chemo- and radiosensitization in cancer models. This guide offers workflow enhancements, protocol specifics, and troubleshooting insights tailored for translational oncology applications.

• Puerarin Promotes Osteogenic Differentiation via Nitric Oxid

  2026-07-22

  The referenced study provides the first direct evidence that puerarin enhances the osteogenic differentiation of rat dental follicle cells (rDFCs) by activating the nitric oxide signaling pathway. Using the pan-NOS inhibitor N(G)-monomethyl-L-arginine acetate (L-NMMA acetate), the authors mechanistically link nitric oxide pathway modulation to osteogenic outcomes, with implications for periodontal tissue engineering.

• MK-4827 (Niraparib): Mechanistic Insights and New Frontiers

  2026-07-21

  Explore the advanced mechanism of action and evolving applications of MK-4827 (Niraparib), a potent PARP-1/-2 inhibitor, in BRCA-mutant and resistant cancer research. This article uniquely bridges mechanistic understanding and translational innovation for next-generation DNA repair studies.

• Rapamycin (Sirolimus): Advanced mTOR Inhibition for Research

  2026-07-21

  Rapamycin (Sirolimus) offers precise, nanomolar mTOR inhibition, enabling advanced dissection of cell growth, proliferation, and survival mechanisms. This article details optimized workflows, troubleshooting strategies, and translational applications—empowering researchers to model disease and interrogate cellular signaling with exceptional reproducibility.

• PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chickens

  2026-07-20

  A recent study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly improves both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. This targeted, sustained-release approach addresses longstanding limitations of current vaccines and represents a major advance for poultry immunology.

• Amikacin Disulfate: Molecular Insights into Protein Complexa

  2026-07-20

  Explore Amikacin disulfate as a semisynthetic aminoglycoside antibiotic with unique protein-binding properties for advanced antibiotic mechanism research. This article reveals new molecular insights and practical assay implications that go beyond standard workflows.

15087 records 1/1006 page Next 12345 下5页 Last page